NSCLCnon-small cell lung cancerdocetaxeldatopotamab deruxtecanplatinum-based chemotherapy
…ibody, gotistobart (ONC-392/BNT316) in patients with metastatic NSCLC resistant to immunotherapy is on the way (NCT05671510); moreove…
126articles mentioning diseases
162disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: non-small cell lung cancer ×
non-small cell lung cancer
This disease is selected. Its supporting articles are shown below.
Articles mentioning non-small cell lung cancer
126 articles · page 5 of 11non-small cell lung cancerNSCLCsitravatinibtislelizumabdocetaxel
…Background Many patients with non-small cell lung cancer (NSCLC) have tumours that are either refractory or develop resi…
colorectal cancernon-small cell lung cancerpancreatic ductal adenocarcinomaPDACselective inhibitorsstandard therapies
…nocarcinoma (PDAC, 90–95%), non-small cell lung cancer (30%) or colorectal cancer (40%).1 The prognosis is particularly bad in the case of pancre…
non-small cell lung cancersotorasibPD-L1iAMG-510
…o KRAS G12C inhibitor sotorasib remains a critical challenge in non-small cell lung cancer treatment. A deeper, rational understanding of resistance mecha…
Non-small cell lung cancerNSCLClung canceroAd-vpxαPD-1
…Background Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and the leading …
non-small cell lung cancerPHT_CTPHT_IOTTPHT_IOTTPHT_CTComplex Oncological CenterPHTSXradiotherapychemotherapy
…tic and treatment pathways and related overall survival (OS) of non-small cell lung cancer patients.Methods This was a longitudinal, historical descriptiv…
non-small cell lung cancerNSCLCimmune checkpoint inhibitors
…igand 1 (PD-L1) expression and tumor mutational burden (TMB) in non-small cell lung cancer (NSCLC), and its potential impact on responses to immune checkp…
non-small cell lung cancerNSCLCimmune checkpoint inhibitorsimmunotherapySMC CohortICIs
…Background Patients with non-small cell lung cancer (NSCLC) exhibit heterogeneous responses to immunotherapy (IT) w…
hepatocellular carcinomanon-small cell lung cancerurothelial carcinomarenal cell carcinomaatezolizumabbevacizumabimmunotherapies
…g cancer, urothelial carcinoma, renal cell carcinoma (RCC), and hepatocellular carcinoma.Results Analyses of the temporal characteristics of atypical re…
NSCLCnon-small cell lung cancerneoadjuvant treatmentUniversity of VeronaClinicalTrials.govsurgeryClinicaltrial.govadjuvant treatment
…aly, comprising two cohorts of patients affected by early stage NSCLC (stages IB–IIIA) epidermal growth factor receptor and anaplasti…
non-small cell lung cancerNSCLCNSCLCsimmunotherapy
…Objective Our study examines how non-small cell lung cancer (NSCLC) survivors undergoing immunotherapy can experience reduc…
non-small cell lung cancerNSCLCDana-Farber Cancer InstituteMemorial Sloan Kettering Cancer Centerchemo-IOchemo-IO
…apy has transformed the therapeutic landscape for patients with non-small cell lung cancer (NSCLC), critical questions remain regarding how detailed smoki…